Tag Archives: Ketamine

RE: International Drug Scheduling; Convention on Psychotropic Substances; Single Convention on Narcotic Drugs; Ocfentanil, Carfentanil, Pregabalin, Tramadol, Cannabidiol, Ketamine, and Eleven Other Substances; Request for Comments

The information contained herein is from the Government website of REGULATIONS.GOV.

They are currently seeking comments on the scheduling of the above named substances.  After browsing through the information I did not see CANNABIS included in this request.

 Cannabidiol, IS INCLUDED. 

I will submit my comments and will post my response here on the website.

Image result for psychotropic substances

Summary

The Food and Drug Administration (FDA) is requesting interested persons to submit comments concerning abuse potential, actual abuse, medical usefulness, trafficking, and impact of scheduling changes on availability for medical use of 17 drug substances. These comments will be considered in preparing a response from the United States to the World Health Organization (WHO) regarding the abuse liability and diversion of these drugs. WHO will use this information to consider whether to recommend that certain international restrictions be placed on these drugs. This notice requesting comments is required by the Controlled Substances Act (the CSA).

Dates

Submit either electronic or written comments by September 13, 2017.

Supplementary Information

I. Background

The United States is a party to the 1971 Convention on Psychotropic Substances (Psychotropic Convention). Article 2 of the Psychotropic Convention provides that if a party to the convention or WHO has information about a substance, which in its opinion may require international control or change in such control, it shall so notify the Secretary-General of the United Nations (the U.N. Secretary-General) and provide the U.N. Secretary-General with information in support of its opinion.

Section 201 of the CSA (21 U.S.C. 811) (Title II of the Comprehensive Drug Abuse Prevention and Control Act of 1970) provides that when WHO notifies the United States under Article 2 of the Psychotropic Convention that it has information that may justify adding a drug or other substances to one of the schedules of the Psychotropic Convention, transferring a drug or substance from one schedule to another, or deleting it from the schedules, the Secretary of State must transmit the notice to the Secretary of Health and Human Services (Secretary of HHS). The Secretary of HHS must then publish the notice in the Federal Register and provide opportunity for interested persons to submit comments that will be considered by HHS in its preparation of the scientific and medical evaluations of the drug or substance.

Links to further information and to post comments:

Docket ID: FDA-2017-N-4515

Agency: Food and Drug Administration (FDA)

Parent Agency: Department of Health and Human Services (HHS)

*View all documents and comments in this Docket

*Public Comments that have already been received and posted.

*SUBMIT YOUR COMMENT THROUGH THIS LINK

*LINK TO DOCUMENTATION IN THE FEDERAL REGISTER

Advertisements